nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0565	0.181	CbGbCtD
Carfilzomib—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0428	0.137	CbGbCtD
Carfilzomib—ABCB1—Betamethasone—systemic lupus erythematosus	0.0367	0.118	CbGbCtD
Carfilzomib—ABCB1—Prednisolone—systemic lupus erythematosus	0.0363	0.116	CbGbCtD
Carfilzomib—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0344	0.11	CbGbCtD
Carfilzomib—ABCB1—Prednisone—systemic lupus erythematosus	0.0342	0.11	CbGbCtD
Carfilzomib—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0325	0.104	CbGbCtD
Carfilzomib—ABCB1—Dexamethasone—systemic lupus erythematosus	0.0214	0.0685	CbGbCtD
Carfilzomib—ABCB1—Methotrexate—systemic lupus erythematosus	0.0172	0.0551	CbGbCtD
Carfilzomib—PSMB10—lymphoid tissue—systemic lupus erythematosus	0.00796	0.05	CbGeAlD
Carfilzomib—PSMB10—lung—systemic lupus erythematosus	0.00657	0.0412	CbGeAlD
Carfilzomib—PSMB10—nervous system—systemic lupus erythematosus	0.00608	0.0382	CbGeAlD
Carfilzomib—PSMB5—nephron tubule—systemic lupus erythematosus	0.006	0.0377	CbGeAlD
Carfilzomib—PSMB10—central nervous system—systemic lupus erythematosus	0.00586	0.0368	CbGeAlD
Carfilzomib—PSMB8—cortex of kidney—systemic lupus erythematosus	0.00582	0.0365	CbGeAlD
Carfilzomib—PSMB2—connective tissue—systemic lupus erythematosus	0.00529	0.0332	CbGeAlD
Carfilzomib—PSMB1—nephron tubule—systemic lupus erythematosus	0.00525	0.033	CbGeAlD
Carfilzomib—PSMB5—cortex of kidney—systemic lupus erythematosus	0.00514	0.0323	CbGeAlD
Carfilzomib—PSMB2—nephron tubule—systemic lupus erythematosus	0.00512	0.0322	CbGeAlD
Carfilzomib—PSMB1—skin of body—systemic lupus erythematosus	0.00489	0.0307	CbGeAlD
Carfilzomib—PSMB8—tendon—systemic lupus erythematosus	0.00482	0.0303	CbGeAlD
Carfilzomib—PSMB2—skin of body—systemic lupus erythematosus	0.00477	0.03	CbGeAlD
Carfilzomib—PSMB8—bone marrow—systemic lupus erythematosus	0.00467	0.0293	CbGeAlD
Carfilzomib—PSMB1—kidney—systemic lupus erythematosus	0.00461	0.029	CbGeAlD
Carfilzomib—PSMB2—kidney—systemic lupus erythematosus	0.0045	0.0283	CbGeAlD
Carfilzomib—PSMB1—cortex of kidney—systemic lupus erythematosus	0.00449	0.0282	CbGeAlD
Carfilzomib—PSMB2—cortex of kidney—systemic lupus erythematosus	0.00438	0.0275	CbGeAlD
Carfilzomib—PSMB5—tendon—systemic lupus erythematosus	0.00426	0.0268	CbGeAlD
Carfilzomib—PSMB8—lung—systemic lupus erythematosus	0.00423	0.0266	CbGeAlD
Carfilzomib—PSMB5—bone marrow—systemic lupus erythematosus	0.00413	0.0259	CbGeAlD
Carfilzomib—PSMB1—lymphoid tissue—systemic lupus erythematosus	0.00396	0.0249	CbGeAlD
Carfilzomib—PSMB2—lymphoid tissue—systemic lupus erythematosus	0.00387	0.0243	CbGeAlD
Carfilzomib—PSMB5—lung—systemic lupus erythematosus	0.00374	0.0235	CbGeAlD
Carfilzomib—PSMB1—tendon—systemic lupus erythematosus	0.00372	0.0234	CbGeAlD
Carfilzomib—PSMB2—tendon—systemic lupus erythematosus	0.00363	0.0228	CbGeAlD
Carfilzomib—PSMB1—bone marrow—systemic lupus erythematosus	0.00361	0.0227	CbGeAlD
Carfilzomib—PSMB2—bone marrow—systemic lupus erythematosus	0.00352	0.0221	CbGeAlD
Carfilzomib—PSMB1—lung—systemic lupus erythematosus	0.00327	0.0205	CbGeAlD
Carfilzomib—PSMB2—lung—systemic lupus erythematosus	0.00319	0.02	CbGeAlD
Carfilzomib—PSMB1—nervous system—systemic lupus erythematosus	0.00303	0.019	CbGeAlD
Carfilzomib—PSMB2—nervous system—systemic lupus erythematosus	0.00295	0.0185	CbGeAlD
Carfilzomib—PSMB1—central nervous system—systemic lupus erythematosus	0.00291	0.0183	CbGeAlD
Carfilzomib—PSMB2—central nervous system—systemic lupus erythematosus	0.00284	0.0179	CbGeAlD
Carfilzomib—ABCB1—blood plasma—systemic lupus erythematosus	0.00152	0.00953	CbGeAlD
Carfilzomib—ABCB1—nephron tubule—systemic lupus erythematosus	0.000782	0.00491	CbGeAlD
Carfilzomib—Renal failure—Cyclosporine—systemic lupus erythematosus	0.00074	0.0037	CcSEcCtD
Carfilzomib—Pneumonia—Mycophenolate mofetil—systemic lupus erythematosus	0.000738	0.00369	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Cyclosporine—systemic lupus erythematosus	0.000738	0.00369	CcSEcCtD
Carfilzomib—Back pain—Leflunomide—systemic lupus erythematosus	0.000737	0.00368	CcSEcCtD
Carfilzomib—Muscle spasms—Leflunomide—systemic lupus erythematosus	0.000733	0.00366	CcSEcCtD
Carfilzomib—Headache—Dapsone—systemic lupus erythematosus	0.00073	0.00365	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Mycophenolate mofetil—systemic lupus erythematosus	0.000724	0.00362	CcSEcCtD
Carfilzomib—Leukopenia—Azathioprine—systemic lupus erythematosus	0.000722	0.00361	CcSEcCtD
Carfilzomib—Renal failure—Mycophenolate mofetil—systemic lupus erythematosus	0.000722	0.00361	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Mycophenolate mofetil—systemic lupus erythematosus	0.00072	0.0036	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Prednisone—systemic lupus erythematosus	0.000712	0.00356	CcSEcCtD
Carfilzomib—Cardiac arrest—Dexamethasone—systemic lupus erythematosus	0.000705	0.00352	CcSEcCtD
Carfilzomib—Cardiac arrest—Betamethasone—systemic lupus erythematosus	0.000705	0.00352	CcSEcCtD
Carfilzomib—Anaemia—Leflunomide—systemic lupus erythematosus	0.000704	0.00352	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Hydrocortisone—systemic lupus erythematosus	0.000697	0.00348	CcSEcCtD
Carfilzomib—Nausea—Dapsone—systemic lupus erythematosus	0.000692	0.00346	CcSEcCtD
Carfilzomib—ABCB1—kidney—systemic lupus erythematosus	0.000687	0.00432	CbGeAlD
Carfilzomib—Arthralgia—Azathioprine—systemic lupus erythematosus	0.000687	0.00343	CcSEcCtD
Carfilzomib—Leukopenia—Leflunomide—systemic lupus erythematosus	0.000682	0.00341	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Prednisolone—systemic lupus erythematosus	0.000675	0.00337	CcSEcCtD
Carfilzomib—Hypokalaemia—Betamethasone—systemic lupus erythematosus	0.000675	0.00337	CcSEcCtD
Carfilzomib—Hypokalaemia—Dexamethasone—systemic lupus erythematosus	0.000675	0.00337	CcSEcCtD
Carfilzomib—Hypoaesthesia—Cyclosporine—systemic lupus erythematosus	0.000672	0.00336	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Prednisolone—systemic lupus erythematosus	0.000671	0.00335	CcSEcCtD
Carfilzomib—ABCB1—cortex of kidney—systemic lupus erythematosus	0.00067	0.0042	CbGeAlD
Carfilzomib—Cough—Leflunomide—systemic lupus erythematosus	0.000665	0.00332	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Hydrocortisone—systemic lupus erythematosus	0.000659	0.00329	CcSEcCtD
Carfilzomib—Hypertension—Leflunomide—systemic lupus erythematosus	0.000658	0.00329	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Triamcinolone—systemic lupus erythematosus	0.000656	0.00328	CcSEcCtD
Carfilzomib—Hypoaesthesia—Mycophenolate mofetil—systemic lupus erythematosus	0.000656	0.00328	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Hydrocortisone—systemic lupus erythematosus	0.000656	0.00328	CcSEcCtD
Carfilzomib—Infection—Azathioprine—systemic lupus erythematosus	0.000654	0.00327	CcSEcCtD
Carfilzomib—Oedema peripheral—Mycophenolate mofetil—systemic lupus erythematosus	0.000649	0.00324	CcSEcCtD
Carfilzomib—Arthralgia—Leflunomide—systemic lupus erythematosus	0.000649	0.00324	CcSEcCtD
Carfilzomib—Sepsis—Methotrexate—systemic lupus erythematosus	0.000645	0.00322	CcSEcCtD
Carfilzomib—Thrombocytopenia—Azathioprine—systemic lupus erythematosus	0.000645	0.00322	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Triamcinolone—systemic lupus erythematosus	0.000621	0.0031	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Methylprednisolone—systemic lupus erythematosus	0.000619	0.0031	CcSEcCtD
Carfilzomib—Infection—Leflunomide—systemic lupus erythematosus	0.000618	0.00309	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Triamcinolone—systemic lupus erythematosus	0.000617	0.00308	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Methylprednisolone—systemic lupus erythematosus	0.000616	0.00308	CcSEcCtD
Carfilzomib—Cardiac arrest—Prednisone—systemic lupus erythematosus	0.000614	0.00307	CcSEcCtD
Carfilzomib—Cardiac disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000612	0.00306	CcSEcCtD
Carfilzomib—Thrombocytopenia—Leflunomide—systemic lupus erythematosus	0.000609	0.00304	CcSEcCtD
Carfilzomib—Chills—Cyclosporine—systemic lupus erythematosus	0.000606	0.00303	CcSEcCtD
Carfilzomib—Hepatic failure—Methotrexate—systemic lupus erythematosus	0.000601	0.003	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Azathioprine—systemic lupus erythematosus	0.0006	0.003	CcSEcCtD
Carfilzomib—Anorexia—Leflunomide—systemic lupus erythematosus	0.000593	0.00296	CcSEcCtD
Carfilzomib—Chills—Mycophenolate mofetil—systemic lupus erythematosus	0.000591	0.00296	CcSEcCtD
Carfilzomib—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.00059	0.00371	CbGeAlD
Carfilzomib—Hypokalaemia—Prednisone—systemic lupus erythematosus	0.000588	0.00294	CcSEcCtD
Carfilzomib—Renal failure acute—Methotrexate—systemic lupus erythematosus	0.000585	0.00292	CcSEcCtD
Carfilzomib—Hyperglycaemia—Dexamethasone—systemic lupus erythematosus	0.000578	0.00289	CcSEcCtD
Carfilzomib—Hyperglycaemia—Betamethasone—systemic lupus erythematosus	0.000578	0.00289	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Leflunomide—systemic lupus erythematosus	0.000567	0.00283	CcSEcCtD
Carfilzomib—Muscle spasms—Cyclosporine—systemic lupus erythematosus	0.000565	0.00283	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Betamethasone—systemic lupus erythematosus	0.000563	0.00282	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Dexamethasone—systemic lupus erythematosus	0.000563	0.00282	CcSEcCtD
Carfilzomib—Insomnia—Leflunomide—systemic lupus erythematosus	0.000562	0.00281	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Dexamethasone—systemic lupus erythematosus	0.00056	0.0028	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Betamethasone—systemic lupus erythematosus	0.00056	0.0028	CcSEcCtD
Carfilzomib—Back pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000555	0.00277	CcSEcCtD
Carfilzomib—Dyspnoea—Leflunomide—systemic lupus erythematosus	0.000554	0.00277	CcSEcCtD
Carfilzomib—Muscle spasms—Mycophenolate mofetil—systemic lupus erythematosus	0.000552	0.00276	CcSEcCtD
Carfilzomib—Anaemia—Cyclosporine—systemic lupus erythematosus	0.000544	0.00272	CcSEcCtD
Carfilzomib—Decreased appetite—Leflunomide—systemic lupus erythematosus	0.000541	0.0027	CcSEcCtD
Carfilzomib—ABCB1—bone marrow—systemic lupus erythematosus	0.000538	0.00338	CbGeAlD
Carfilzomib—Fatigue—Leflunomide—systemic lupus erythematosus	0.000536	0.00268	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Hydrocortisone—systemic lupus erythematosus	0.000536	0.0442	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Hydrocortisone—systemic lupus erythematosus	0.000536	0.0442	CbGdCrCtD
Carfilzomib—Pain—Leflunomide—systemic lupus erythematosus	0.000532	0.00266	CcSEcCtD
Carfilzomib—Constipation—Leflunomide—systemic lupus erythematosus	0.000532	0.00266	CcSEcCtD
Carfilzomib—Anaemia—Mycophenolate mofetil—systemic lupus erythematosus	0.00053	0.00265	CcSEcCtD
Carfilzomib—Leukopenia—Cyclosporine—systemic lupus erythematosus	0.000526	0.00263	CcSEcCtD
Carfilzomib—Cardiac disorder—Methylprednisolone—systemic lupus erythematosus	0.000524	0.00262	CcSEcCtD
Carfilzomib—Neutropenia—Prednisone—systemic lupus erythematosus	0.000522	0.00261	CcSEcCtD
Carfilzomib—Body temperature increased—Azathioprine—systemic lupus erythematosus	0.000521	0.0026	CcSEcCtD
Carfilzomib—Leukopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000514	0.00257	CcSEcCtD
Carfilzomib—Cough—Cyclosporine—systemic lupus erythematosus	0.000513	0.00256	CcSEcCtD
Carfilzomib—Hypertension—Cyclosporine—systemic lupus erythematosus	0.000508	0.00254	CcSEcCtD
Carfilzomib—PSMB9—Betamethasone—Methylprednisolone—systemic lupus erythematosus	0.000505	0.0417	CbGdCrCtD
Carfilzomib—PSMB9—Dexamethasone—Methylprednisolone—systemic lupus erythematosus	0.000505	0.0417	CbGdCrCtD
Carfilzomib—Hyperglycaemia—Prednisone—systemic lupus erythematosus	0.000503	0.00252	CcSEcCtD
Carfilzomib—Arthralgia—Cyclosporine—systemic lupus erythematosus	0.000501	0.0025	CcSEcCtD
Carfilzomib—Cough—Mycophenolate mofetil—systemic lupus erythematosus	0.000501	0.0025	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Betamethasone—systemic lupus erythematosus	0.000497	0.041	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Dexamethasone—systemic lupus erythematosus	0.000497	0.041	CbGdCrCtD
Carfilzomib—Hypertension—Mycophenolate mofetil—systemic lupus erythematosus	0.000495	0.00248	CcSEcCtD
Carfilzomib—Body temperature increased—Leflunomide—systemic lupus erythematosus	0.000492	0.00246	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Prednisone—systemic lupus erythematosus	0.000491	0.00245	CcSEcCtD
Carfilzomib—Arthralgia—Mycophenolate mofetil—systemic lupus erythematosus	0.000488	0.00244	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Prednisone—systemic lupus erythematosus	0.000488	0.00244	CcSEcCtD
Carfilzomib—ABCB1—lung—systemic lupus erythematosus	0.000487	0.00306	CbGeAlD
Carfilzomib—PSMB9—Dexamethasone—Triamcinolone—systemic lupus erythematosus	0.000486	0.0401	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Triamcinolone—systemic lupus erythematosus	0.000486	0.0401	CbGdCrCtD
Carfilzomib—Infection—Cyclosporine—systemic lupus erythematosus	0.000477	0.00238	CcSEcCtD
Carfilzomib—Back pain—Triamcinolone—systemic lupus erythematosus	0.000476	0.00238	CcSEcCtD
Carfilzomib—Thrombocytopenia—Cyclosporine—systemic lupus erythematosus	0.00047	0.00235	CcSEcCtD
Carfilzomib—Infection—Mycophenolate mofetil—systemic lupus erythematosus	0.000465	0.00232	CcSEcCtD
Carfilzomib—Hypertension—Prednisolone—systemic lupus erythematosus	0.000462	0.00231	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Prednisone—systemic lupus erythematosus	0.000461	0.038	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Prednisone—systemic lupus erythematosus	0.000461	0.038	CbGdCrCtD
Carfilzomib—Thrombocytopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000458	0.00229	CcSEcCtD
Carfilzomib—Anorexia—Cyclosporine—systemic lupus erythematosus	0.000458	0.00229	CcSEcCtD
Carfilzomib—Hypertension—Hydrocortisone—systemic lupus erythematosus	0.000451	0.00226	CcSEcCtD
Carfilzomib—ABCB1—nervous system—systemic lupus erythematosus	0.000451	0.00283	CbGeAlD
Carfilzomib—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.000451	0.00225	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Prednisolone—systemic lupus erythematosus	0.00045	0.0371	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Prednisolone—systemic lupus erythematosus	0.00045	0.0371	CbGdCrCtD
Carfilzomib—Anorexia—Mycophenolate mofetil—systemic lupus erythematosus	0.000446	0.00223	CcSEcCtD
Carfilzomib—Asthenia—Leflunomide—systemic lupus erythematosus	0.000446	0.00223	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Cyclosporine—systemic lupus erythematosus	0.000437	0.00219	CcSEcCtD
Carfilzomib—Neutropenia—Methotrexate—systemic lupus erythematosus	0.000436	0.00218	CcSEcCtD
Carfilzomib—Dizziness—Azathioprine—systemic lupus erythematosus	0.000435	0.00218	CcSEcCtD
Carfilzomib—ABCB1—central nervous system—systemic lupus erythematosus	0.000434	0.00273	CbGeAlD
Carfilzomib—Insomnia—Cyclosporine—systemic lupus erythematosus	0.000434	0.00217	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Methotrexate—systemic lupus erythematosus	0.000433	0.00217	CcSEcCtD
Carfilzomib—Cough—Triamcinolone—systemic lupus erythematosus	0.000429	0.00215	CcSEcCtD
Carfilzomib—Dyspnoea—Cyclosporine—systemic lupus erythematosus	0.000428	0.00214	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.000427	0.00213	CcSEcCtD
Carfilzomib—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000426	0.00213	CcSEcCtD
Carfilzomib—Hypertension—Triamcinolone—systemic lupus erythematosus	0.000425	0.00212	CcSEcCtD
Carfilzomib—Hypertension—Methylprednisolone—systemic lupus erythematosus	0.000424	0.00212	CcSEcCtD
Carfilzomib—Infection—Hydrocortisone—systemic lupus erythematosus	0.000424	0.00212	CcSEcCtD
Carfilzomib—Insomnia—Mycophenolate mofetil—systemic lupus erythematosus	0.000423	0.00212	CcSEcCtD
Carfilzomib—Vomiting—Azathioprine—systemic lupus erythematosus	0.000419	0.00209	CcSEcCtD
Carfilzomib—PSMB8—Medrysone—Hydrocortisone—systemic lupus erythematosus	0.000418	0.0345	CbGdCrCtD
Carfilzomib—Pneumonia—Methotrexate—systemic lupus erythematosus	0.000418	0.00209	CcSEcCtD
Carfilzomib—Arthralgia—Methylprednisolone—systemic lupus erythematosus	0.000418	0.00209	CcSEcCtD
Carfilzomib—Dyspnoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000417	0.00209	CcSEcCtD
Carfilzomib—Decreased appetite—Cyclosporine—systemic lupus erythematosus	0.000417	0.00209	CcSEcCtD
Carfilzomib—Fatigue—Cyclosporine—systemic lupus erythematosus	0.000414	0.00207	CcSEcCtD
Carfilzomib—Headache—Azathioprine—systemic lupus erythematosus	0.000413	0.00206	CcSEcCtD
Carfilzomib—Dizziness—Leflunomide—systemic lupus erythematosus	0.000411	0.00206	CcSEcCtD
Carfilzomib—Pain—Cyclosporine—systemic lupus erythematosus	0.00041	0.00205	CcSEcCtD
Carfilzomib—Constipation—Cyclosporine—systemic lupus erythematosus	0.00041	0.00205	CcSEcCtD
Carfilzomib—Renal failure—Methotrexate—systemic lupus erythematosus	0.000409	0.00204	CcSEcCtD
Carfilzomib—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	0.000407	0.00203	CcSEcCtD
Carfilzomib—Anorexia—Hydrocortisone—systemic lupus erythematosus	0.000407	0.00203	CcSEcCtD
Carfilzomib—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.0004	0.002	CcSEcCtD
Carfilzomib—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.0004	0.002	CcSEcCtD
Carfilzomib—Infection—Triamcinolone—systemic lupus erythematosus	0.000399	0.00199	CcSEcCtD
Carfilzomib—Infection—Methylprednisolone—systemic lupus erythematosus	0.000398	0.00199	CcSEcCtD
Carfilzomib—Vomiting—Leflunomide—systemic lupus erythematosus	0.000395	0.00198	CcSEcCtD
Carfilzomib—Insomnia—Prednisolone—systemic lupus erythematosus	0.000395	0.00197	CcSEcCtD
Carfilzomib—PSMB8—Medrysone—Methylprednisolone—systemic lupus erythematosus	0.000395	0.0325	CbGdCrCtD
Carfilzomib—Nausea—Azathioprine—systemic lupus erythematosus	0.000391	0.00195	CcSEcCtD
Carfilzomib—Headache—Leflunomide—systemic lupus erythematosus	0.00039	0.00195	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000389	0.00194	CcSEcCtD
Carfilzomib—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.000386	0.00193	CcSEcCtD
Carfilzomib—Hypertension—Dexamethasone—systemic lupus erythematosus	0.000386	0.00193	CcSEcCtD
Carfilzomib—Hypertension—Betamethasone—systemic lupus erythematosus	0.000386	0.00193	CcSEcCtD
Carfilzomib—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000379	0.0019	CcSEcCtD
Carfilzomib—Pain—Prednisolone—systemic lupus erythematosus	0.000373	0.00187	CcSEcCtD
Carfilzomib—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000371	0.00185	CcSEcCtD
Carfilzomib—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.00037	0.00185	CcSEcCtD
Carfilzomib—Nausea—Leflunomide—systemic lupus erythematosus	0.000369	0.00185	CcSEcCtD
Carfilzomib—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000368	0.00184	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000366	0.00183	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000365	0.00182	CcSEcCtD
Carfilzomib—Pain—Hydrocortisone—systemic lupus erythematosus	0.000365	0.00182	CcSEcCtD
Carfilzomib—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000363	0.00182	CcSEcCtD
Carfilzomib—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000362	0.00181	CcSEcCtD
Carfilzomib—Infection—Dexamethasone—systemic lupus erythematosus	0.000362	0.00181	CcSEcCtD
Carfilzomib—Infection—Betamethasone—systemic lupus erythematosus	0.000362	0.00181	CcSEcCtD
Carfilzomib—Anaemia—Prednisone—systemic lupus erythematosus	0.000359	0.0018	CcSEcCtD
Carfilzomib—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000358	0.00179	CcSEcCtD
Carfilzomib—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000357	0.00178	CcSEcCtD
Carfilzomib—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000357	0.00178	CcSEcCtD
Carfilzomib—PSMB8—Medrysone—Prednisolone—systemic lupus erythematosus	0.000352	0.029	CbGdCrCtD
Carfilzomib—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000347	0.00174	CcSEcCtD
Carfilzomib—Anorexia—Betamethasone—systemic lupus erythematosus	0.000347	0.00174	CcSEcCtD
Carfilzomib—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.000346	0.00173	CcSEcCtD
Carfilzomib—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000346	0.00173	CcSEcCtD
Carfilzomib—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000346	0.00173	CcSEcCtD
Carfilzomib—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000344	0.00172	CcSEcCtD
Carfilzomib—Pain—Triamcinolone—systemic lupus erythematosus	0.000343	0.00172	CcSEcCtD
Carfilzomib—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000337	0.00169	CcSEcCtD
Carfilzomib—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000336	0.00168	CcSEcCtD
Carfilzomib—Hypertension—Prednisone—systemic lupus erythematosus	0.000336	0.00168	CcSEcCtD
Carfilzomib—Chills—Methotrexate—systemic lupus erythematosus	0.000335	0.00167	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000332	0.00166	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000332	0.00166	CcSEcCtD
Carfilzomib—Arthralgia—Prednisone—systemic lupus erythematosus	0.000331	0.00165	CcSEcCtD
Carfilzomib—Insomnia—Betamethasone—systemic lupus erythematosus	0.00033	0.00165	CcSEcCtD
Carfilzomib—Insomnia—Dexamethasone—systemic lupus erythematosus	0.00033	0.00165	CcSEcCtD
Carfilzomib—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000328	0.00164	CcSEcCtD
Carfilzomib—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.00032	0.0016	CcSEcCtD
Carfilzomib—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000318	0.00159	CcSEcCtD
Carfilzomib—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000317	0.00159	CcSEcCtD
Carfilzomib—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000317	0.00158	CcSEcCtD
Carfilzomib—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000317	0.00158	CcSEcCtD
Carfilzomib—Infection—Prednisone—systemic lupus erythematosus	0.000315	0.00158	CcSEcCtD
Carfilzomib—Back pain—Methotrexate—systemic lupus erythematosus	0.000314	0.00157	CcSEcCtD
Carfilzomib—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000314	0.00157	CcSEcCtD
Carfilzomib—Fatigue—Betamethasone—systemic lupus erythematosus	0.000314	0.00157	CcSEcCtD
Carfilzomib—Pain—Dexamethasone—systemic lupus erythematosus	0.000312	0.00156	CcSEcCtD
Carfilzomib—Pain—Betamethasone—systemic lupus erythematosus	0.000312	0.00156	CcSEcCtD
Carfilzomib—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.00031	0.00155	CcSEcCtD
Carfilzomib—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000306	0.00153	CcSEcCtD
Carfilzomib—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000305	0.00153	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Hydrocortisone—systemic lupus erythematosus	0.000303	0.025	CbGdCrCtD
Carfilzomib—Anorexia—Prednisone—systemic lupus erythematosus	0.000303	0.00151	CcSEcCtD
Carfilzomib—Headache—Cyclosporine—systemic lupus erythematosus	0.000301	0.0015	CcSEcCtD
Carfilzomib—Anaemia—Methotrexate—systemic lupus erythematosus	0.0003	0.0015	CcSEcCtD
Carfilzomib—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000298	0.00149	CcSEcCtD
Carfilzomib—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000293	0.00147	CcSEcCtD
Carfilzomib—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000292	0.00146	CcSEcCtD
Carfilzomib—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000291	0.00145	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000289	0.00145	CcSEcCtD
Carfilzomib—Dizziness—Prednisolone—systemic lupus erythematosus	0.000289	0.00144	CcSEcCtD
Carfilzomib—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000288	0.00144	CcSEcCtD
Carfilzomib—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000288	0.00144	CcSEcCtD
Carfilzomib—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000288	0.00144	CcSEcCtD
Carfilzomib—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000288	0.00144	CcSEcCtD
Carfilzomib—Insomnia—Prednisone—systemic lupus erythematosus	0.000287	0.00143	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Methylprednisolone—systemic lupus erythematosus	0.000286	0.0236	CbGdCrCtD
Carfilzomib—Nausea—Cyclosporine—systemic lupus erythematosus	0.000285	0.00142	CcSEcCtD
Carfilzomib—Cough—Methotrexate—systemic lupus erythematosus	0.000284	0.00142	CcSEcCtD
Carfilzomib—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000282	0.00141	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Betamethasone—systemic lupus erythematosus	0.000281	0.0232	CbGdCrCtD
Carfilzomib—PSMB8—Fluorometholone—Dexamethasone—systemic lupus erythematosus	0.000281	0.0232	CbGdCrCtD
Carfilzomib—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000278	0.00139	CcSEcCtD
Carfilzomib—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000277	0.00138	CcSEcCtD
Carfilzomib—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000276	0.00138	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Triamcinolone—systemic lupus erythematosus	0.000275	0.0227	CbGdCrCtD
Carfilzomib—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000274	0.00137	CcSEcCtD
Carfilzomib—Fatigue—Prednisone—systemic lupus erythematosus	0.000274	0.00137	CcSEcCtD
Carfilzomib—Headache—Prednisolone—systemic lupus erythematosus	0.000274	0.00137	CcSEcCtD
Carfilzomib—Constipation—Prednisone—systemic lupus erythematosus	0.000271	0.00136	CcSEcCtD
Carfilzomib—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000271	0.00136	CcSEcCtD
Carfilzomib—Headache—Hydrocortisone—systemic lupus erythematosus	0.000267	0.00134	CcSEcCtD
Carfilzomib—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000266	0.00133	CcSEcCtD
Carfilzomib—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000265	0.00132	CcSEcCtD
Carfilzomib—Infection—Methotrexate—systemic lupus erythematosus	0.000264	0.00132	CcSEcCtD
Carfilzomib—Asthenia—Betamethasone—systemic lupus erythematosus	0.000261	0.00131	CcSEcCtD
Carfilzomib—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000261	0.00131	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Prednisone—systemic lupus erythematosus	0.000261	0.0215	CbGdCrCtD
Carfilzomib—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.00026	0.0013	CcSEcCtD
Carfilzomib—Nausea—Prednisolone—systemic lupus erythematosus	0.000259	0.0013	CcSEcCtD
Carfilzomib—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000255	0.00128	CcSEcCtD
Carfilzomib—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000255	0.00127	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Prednisolone—systemic lupus erythematosus	0.000255	0.021	CbGdCrCtD
Carfilzomib—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000253	0.00127	CcSEcCtD
Carfilzomib—Anorexia—Methotrexate—systemic lupus erythematosus	0.000253	0.00126	CcSEcCtD
Carfilzomib—Headache—Triamcinolone—systemic lupus erythematosus	0.000252	0.00126	CcSEcCtD
Carfilzomib—Headache—Methylprednisolone—systemic lupus erythematosus	0.000251	0.00125	CcSEcCtD
Carfilzomib—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000251	0.00125	CcSEcCtD
Carfilzomib—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000249	0.00125	CcSEcCtD
Carfilzomib—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000249	0.00125	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000242	0.00121	CcSEcCtD
Carfilzomib—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000241	0.0012	CcSEcCtD
Carfilzomib—Dizziness—Betamethasone—systemic lupus erythematosus	0.000241	0.0012	CcSEcCtD
Carfilzomib—Insomnia—Methotrexate—systemic lupus erythematosus	0.00024	0.0012	CcSEcCtD
Carfilzomib—Nausea—Triamcinolone—systemic lupus erythematosus	0.000239	0.00119	CcSEcCtD
Carfilzomib—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000238	0.00119	CcSEcCtD
Carfilzomib—Dyspnoea—Methotrexate—systemic lupus erythematosus	0.000236	0.00118	CcSEcCtD
Carfilzomib—PSMB8—Testosterone Propionate—Hydrocortisone—systemic lupus erythematosus	0.000233	0.0192	CbGdCrCtD
Carfilzomib—Vomiting—Betamethasone—systemic lupus erythematosus	0.000232	0.00116	CcSEcCtD
Carfilzomib—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000232	0.00116	CcSEcCtD
Carfilzomib—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000231	0.00115	CcSEcCtD
Carfilzomib—Fatigue—Methotrexate—systemic lupus erythematosus	0.000229	0.00114	CcSEcCtD
Carfilzomib—Headache—Betamethasone—systemic lupus erythematosus	0.000228	0.00114	CcSEcCtD
Carfilzomib—Headache—Dexamethasone—systemic lupus erythematosus	0.000228	0.00114	CcSEcCtD
Carfilzomib—Asthenia—Prednisone—systemic lupus erythematosus	0.000228	0.00114	CcSEcCtD
Carfilzomib—Pain—Methotrexate—systemic lupus erythematosus	0.000227	0.00113	CcSEcCtD
Carfilzomib—PSMB8—Diflorasone—Methylprednisolone—systemic lupus erythematosus	0.000218	0.0179	CbGdCrCtD
Carfilzomib—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000217	0.00109	CcSEcCtD
Carfilzomib—Nausea—Dexamethasone—systemic lupus erythematosus	0.000216	0.00108	CcSEcCtD
Carfilzomib—Nausea—Betamethasone—systemic lupus erythematosus	0.000216	0.00108	CcSEcCtD
Carfilzomib—PSMB8—Diflorasone—Betamethasone—systemic lupus erythematosus	0.000214	0.0177	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Dexamethasone—systemic lupus erythematosus	0.000214	0.0177	CbGdCrCtD
Carfilzomib—Dizziness—Prednisone—systemic lupus erythematosus	0.00021	0.00105	CcSEcCtD
Carfilzomib—Body temperature increased—Methotrexate—systemic lupus erythematosus	0.00021	0.00105	CcSEcCtD
Carfilzomib—PSMB8—Diflorasone—Triamcinolone—systemic lupus erythematosus	0.000209	0.0173	CbGdCrCtD
Carfilzomib—Vomiting—Prednisone—systemic lupus erythematosus	0.000202	0.00101	CcSEcCtD
Carfilzomib—Headache—Prednisone—systemic lupus erythematosus	0.000199	0.000994	CcSEcCtD
Carfilzomib—PSMB8—Diflorasone—Prednisone—systemic lupus erythematosus	0.000199	0.0164	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Prednisolone—systemic lupus erythematosus	0.000194	0.016	CbGdCrCtD
Carfilzomib—Asthenia—Methotrexate—systemic lupus erythematosus	0.00019	0.000951	CcSEcCtD
Carfilzomib—Nausea—Prednisone—systemic lupus erythematosus	0.000189	0.000942	CcSEcCtD
Carfilzomib—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.000181	0.000907	CcSEcCtD
Carfilzomib—Dizziness—Methotrexate—systemic lupus erythematosus	0.000175	0.000877	CcSEcCtD
Carfilzomib—PSMB8—Norethindrone—Hydrocortisone—systemic lupus erythematosus	0.000175	0.0144	CbGdCrCtD
Carfilzomib—Vomiting—Methotrexate—systemic lupus erythematosus	0.000169	0.000843	CcSEcCtD
Carfilzomib—Headache—Methotrexate—systemic lupus erythematosus	0.000166	0.00083	CcSEcCtD
Carfilzomib—Nausea—Methotrexate—systemic lupus erythematosus	0.000158	0.000787	CcSEcCtD
Carfilzomib—PSMB8—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	0.000139	0.0115	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Hydrocortisone—systemic lupus erythematosus	0.000124	0.0102	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Hydrocortisone—systemic lupus erythematosus	0.000124	0.0102	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Methylprednisolone—systemic lupus erythematosus	0.000117	0.00962	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Methylprednisolone—systemic lupus erythematosus	0.000117	0.00962	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Betamethasone—systemic lupus erythematosus	0.000115	0.00947	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Dexamethasone—systemic lupus erythematosus	0.000115	0.00947	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Triamcinolone—systemic lupus erythematosus	0.000112	0.00926	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Triamcinolone—systemic lupus erythematosus	0.000112	0.00926	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Prednisone—systemic lupus erythematosus	0.000107	0.00878	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Prednisone—systemic lupus erythematosus	0.000107	0.00878	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Prednisolone—systemic lupus erythematosus	0.000104	0.00857	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Prednisolone—systemic lupus erythematosus	0.000104	0.00857	CbGdCrCtD
Carfilzomib—PSMB10—Signaling Pathways—C3—systemic lupus erythematosus	4.79e-05	0.000151	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—NOS3—systemic lupus erythematosus	4.77e-05	0.000151	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—C3—systemic lupus erythematosus	4.77e-05	0.000151	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CD4—systemic lupus erythematosus	4.76e-05	0.00015	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—NOS3—systemic lupus erythematosus	4.75e-05	0.00015	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CD4—systemic lupus erythematosus	4.74e-05	0.00015	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD80—systemic lupus erythematosus	4.73e-05	0.000149	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD80—systemic lupus erythematosus	4.73e-05	0.000149	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD80—systemic lupus erythematosus	4.73e-05	0.000149	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD80—systemic lupus erythematosus	4.66e-05	0.000147	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—PPARG—systemic lupus erythematosus	4.65e-05	0.000147	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—PPARG—systemic lupus erythematosus	4.62e-05	0.000146	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—PPARG—systemic lupus erythematosus	4.53e-05	0.000143	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—PPARG—systemic lupus erythematosus	4.53e-05	0.000143	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—PPARG—systemic lupus erythematosus	4.53e-05	0.000143	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CDKN1B—systemic lupus erythematosus	4.48e-05	0.000141	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—PPARG—systemic lupus erythematosus	4.46e-05	0.000141	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CDKN1B—systemic lupus erythematosus	4.45e-05	0.000141	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—CD4—systemic lupus erythematosus	4.4e-05	0.000139	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	4.38e-05	0.000138	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL2—systemic lupus erythematosus	4.38e-05	0.000138	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—CD4—systemic lupus erythematosus	4.37e-05	0.000138	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CD80—systemic lupus erythematosus	4.36e-05	0.000138	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CD80—systemic lupus erythematosus	4.36e-05	0.000138	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CD80—systemic lupus erythematosus	4.36e-05	0.000138	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—PTGS2—systemic lupus erythematosus	4.36e-05	0.000138	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL2—systemic lupus erythematosus	4.36e-05	0.000138	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—PTGS2—systemic lupus erythematosus	4.34e-05	0.000137	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CD80—systemic lupus erythematosus	4.3e-05	0.000136	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—F2—systemic lupus erythematosus	4.21e-05	0.000133	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—F2—systemic lupus erythematosus	4.19e-05	0.000132	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—ALB—systemic lupus erythematosus	4.18e-05	0.000132	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—ALB—systemic lupus erythematosus	4.16e-05	0.000131	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	4.15e-05	0.000131	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—CDKN1B—systemic lupus erythematosus	4.13e-05	0.000131	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CDKN1A—systemic lupus erythematosus	4.13e-05	0.00013	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—CDKN1B—systemic lupus erythematosus	4.11e-05	0.00013	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CDKN1A—systemic lupus erythematosus	4.11e-05	0.00013	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CD80—systemic lupus erythematosus	4.03e-05	0.000127	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CD80—systemic lupus erythematosus	4.01e-05	0.000127	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—NOS3—systemic lupus erythematosus	4e-05	0.000126	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—TYK2—systemic lupus erythematosus	3.99e-05	0.000126	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—TYK2—systemic lupus erythematosus	3.99e-05	0.000126	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—TYK2—systemic lupus erythematosus	3.99e-05	0.000126	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—NOS3—systemic lupus erythematosus	3.98e-05	0.000126	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—TYK2—systemic lupus erythematosus	3.93e-05	0.000124	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—EP300—systemic lupus erythematosus	3.93e-05	0.000124	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—JAK1—systemic lupus erythematosus	3.92e-05	0.000124	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—JAK1—systemic lupus erythematosus	3.92e-05	0.000124	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—JAK1—systemic lupus erythematosus	3.92e-05	0.000124	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—EP300—systemic lupus erythematosus	3.91e-05	0.000124	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—JAK1—systemic lupus erythematosus	3.86e-05	0.000122	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	3.83e-05	0.000121	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—CDKN1A—systemic lupus erythematosus	3.81e-05	0.00012	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—CDKN1A—systemic lupus erythematosus	3.8e-05	0.00012	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CCL2—systemic lupus erythematosus	3.75e-05	0.000118	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IFNG—systemic lupus erythematosus	3.74e-05	0.000118	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IFNG—systemic lupus erythematosus	3.74e-05	0.000118	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IFNG—systemic lupus erythematosus	3.74e-05	0.000118	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CCL2—systemic lupus erythematosus	3.73e-05	0.000118	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CCR5—systemic lupus erythematosus	3.71e-05	0.000117	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CCR5—systemic lupus erythematosus	3.71e-05	0.000117	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CCR5—systemic lupus erythematosus	3.71e-05	0.000117	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—TYK2—systemic lupus erythematosus	3.68e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—TYK2—systemic lupus erythematosus	3.68e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—TYK2—systemic lupus erythematosus	3.68e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IFNG—systemic lupus erythematosus	3.68e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CCR5—systemic lupus erythematosus	3.66e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.66e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.66e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.66e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—PTGS2—systemic lupus erythematosus	3.65e-05	0.000115	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	3.64e-05	0.000115	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—PTGS2—systemic lupus erythematosus	3.64e-05	0.000115	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—TYK2—systemic lupus erythematosus	3.63e-05	0.000115	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—C3—systemic lupus erythematosus	3.63e-05	0.000115	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—C3—systemic lupus erythematosus	3.63e-05	0.000115	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—C3—systemic lupus erythematosus	3.63e-05	0.000115	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—EP300—systemic lupus erythematosus	3.63e-05	0.000115	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—NOS3—systemic lupus erythematosus	3.62e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—NOS3—systemic lupus erythematosus	3.62e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—NOS3—systemic lupus erythematosus	3.62e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—EP300—systemic lupus erythematosus	3.61e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.61e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD4—systemic lupus erythematosus	3.61e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD4—systemic lupus erythematosus	3.61e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD4—systemic lupus erythematosus	3.61e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—C3—systemic lupus erythematosus	3.58e-05	0.000113	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—NOS3—systemic lupus erythematosus	3.56e-05	0.000113	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD4—systemic lupus erythematosus	3.56e-05	0.000112	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PPARG—systemic lupus erythematosus	3.52e-05	0.000111	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PPARG—systemic lupus erythematosus	3.52e-05	0.000111	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PPARG—systemic lupus erythematosus	3.52e-05	0.000111	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	3.5e-05	0.000111	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PPARG—systemic lupus erythematosus	3.47e-05	0.00011	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	3.45e-05	0.000109	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TYK2—systemic lupus erythematosus	3.4e-05	0.000108	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CDKN1B—systemic lupus erythematosus	3.39e-05	0.000107	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CDKN1B—systemic lupus erythematosus	3.39e-05	0.000107	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CDKN1B—systemic lupus erythematosus	3.39e-05	0.000107	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TYK2—systemic lupus erythematosus	3.39e-05	0.000107	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CDKN1B—systemic lupus erythematosus	3.34e-05	0.000106	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—NOS3—systemic lupus erythematosus	3.34e-05	0.000106	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CD4—systemic lupus erythematosus	3.33e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CD4—systemic lupus erythematosus	3.33e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CD4—systemic lupus erythematosus	3.33e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—NOS3—systemic lupus erythematosus	3.32e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL2—systemic lupus erythematosus	3.32e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL2—systemic lupus erythematosus	3.32e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL2—systemic lupus erythematosus	3.32e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—PTGS2—systemic lupus erythematosus	3.31e-05	0.000104	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—PTGS2—systemic lupus erythematosus	3.31e-05	0.000104	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—PTGS2—systemic lupus erythematosus	3.31e-05	0.000104	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CD4—systemic lupus erythematosus	3.28e-05	0.000104	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL2—systemic lupus erythematosus	3.27e-05	0.000103	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—PTGS2—systemic lupus erythematosus	3.26e-05	0.000103	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—F2—systemic lupus erythematosus	3.19e-05	0.000101	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—F2—systemic lupus erythematosus	3.19e-05	0.000101	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—F2—systemic lupus erythematosus	3.19e-05	0.000101	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	3.17e-05	0.0001	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—ALB—systemic lupus erythematosus	3.17e-05	0.0001	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—ALB—systemic lupus erythematosus	3.17e-05	0.0001	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—ALB—systemic lupus erythematosus	3.17e-05	0.0001	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—TGFB1—systemic lupus erythematosus	3.15e-05	9.96e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—F2—systemic lupus erythematosus	3.14e-05	9.92e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—TGFB1—systemic lupus erythematosus	3.14e-05	9.92e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CDKN1B—systemic lupus erythematosus	3.13e-05	9.89e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CDKN1B—systemic lupus erythematosus	3.13e-05	9.89e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CDKN1B—systemic lupus erythematosus	3.13e-05	9.89e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CDKN1A—systemic lupus erythematosus	3.13e-05	9.89e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CDKN1A—systemic lupus erythematosus	3.13e-05	9.89e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CDKN1A—systemic lupus erythematosus	3.13e-05	9.89e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—ALB—systemic lupus erythematosus	3.12e-05	9.86e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CDKN1B—systemic lupus erythematosus	3.09e-05	9.75e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CDKN1A—systemic lupus erythematosus	3.09e-05	9.75e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CD80—systemic lupus erythematosus	3.06e-05	9.65e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CD80—systemic lupus erythematosus	3.06e-05	9.65e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CD80—systemic lupus erythematosus	3.06e-05	9.65e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—EP300—systemic lupus erythematosus	3.04e-05	9.6e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—NOS3—systemic lupus erythematosus	3.03e-05	9.56e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—NOS3—systemic lupus erythematosus	3.03e-05	9.56e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—NOS3—systemic lupus erythematosus	3.03e-05	9.56e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—EP300—systemic lupus erythematosus	3.02e-05	9.55e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CD80—systemic lupus erythematosus	3.01e-05	9.52e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—NOS3—systemic lupus erythematosus	2.99e-05	9.43e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—EP300—systemic lupus erythematosus	2.98e-05	9.41e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—EP300—systemic lupus erythematosus	2.98e-05	9.41e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—EP300—systemic lupus erythematosus	2.98e-05	9.41e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	2.96e-05	9.34e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—EP300—systemic lupus erythematosus	2.94e-05	9.28e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	2.93e-05	9.24e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.89e-05	9.14e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CDKN1A—systemic lupus erythematosus	2.89e-05	9.13e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CDKN1A—systemic lupus erythematosus	2.89e-05	9.13e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CDKN1A—systemic lupus erythematosus	2.89e-05	9.13e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.88e-05	9.1e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CDKN1A—systemic lupus erythematosus	2.85e-05	9e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CCL2—systemic lupus erythematosus	2.84e-05	8.97e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CCL2—systemic lupus erythematosus	2.84e-05	8.97e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CCL2—systemic lupus erythematosus	2.84e-05	8.97e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL2—systemic lupus erythematosus	2.83e-05	8.95e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL2—systemic lupus erythematosus	2.82e-05	8.9e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CCL2—systemic lupus erythematosus	2.8e-05	8.85e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PTGS2—systemic lupus erythematosus	2.77e-05	8.75e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PTGS2—systemic lupus erythematosus	2.77e-05	8.75e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PTGS2—systemic lupus erythematosus	2.77e-05	8.75e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—EP300—systemic lupus erythematosus	2.75e-05	8.69e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—EP300—systemic lupus erythematosus	2.75e-05	8.69e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—EP300—systemic lupus erythematosus	2.75e-05	8.69e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PTGS2—systemic lupus erythematosus	2.73e-05	8.62e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—EP300—systemic lupus erythematosus	2.71e-05	8.56e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—MMP9—systemic lupus erythematosus	2.68e-05	8.47e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.67e-05	8.44e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MMP9—systemic lupus erythematosus	2.67e-05	8.43e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.66e-05	8.4e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TYK2—systemic lupus erythematosus	2.58e-05	8.15e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TYK2—systemic lupus erythematosus	2.58e-05	8.15e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TYK2—systemic lupus erythematosus	2.58e-05	8.15e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL6—systemic lupus erythematosus	2.57e-05	8.13e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL6—systemic lupus erythematosus	2.56e-05	8.09e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TYK2—systemic lupus erythematosus	2.54e-05	8.03e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—EP300—systemic lupus erythematosus	2.54e-05	8.03e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NOS3—systemic lupus erythematosus	2.53e-05	8e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NOS3—systemic lupus erythematosus	2.53e-05	8e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NOS3—systemic lupus erythematosus	2.53e-05	8e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—EP300—systemic lupus erythematosus	2.53e-05	7.99e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NOS3—systemic lupus erythematosus	2.5e-05	7.88e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.41e-05	7.6e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.4e-05	7.57e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—TGFB1—systemic lupus erythematosus	2.39e-05	7.55e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—TGFB1—systemic lupus erythematosus	2.39e-05	7.55e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—TGFB1—systemic lupus erythematosus	2.39e-05	7.55e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—IL6—systemic lupus erythematosus	2.38e-05	7.51e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—IL6—systemic lupus erythematosus	2.37e-05	7.47e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—TGFB1—systemic lupus erythematosus	2.36e-05	7.45e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—EP300—systemic lupus erythematosus	2.3e-05	7.28e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—EP300—systemic lupus erythematosus	2.3e-05	7.28e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—EP300—systemic lupus erythematosus	2.3e-05	7.28e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—EP300—systemic lupus erythematosus	2.27e-05	7.17e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.21e-05	6.98e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.2e-05	6.94e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.19e-05	6.93e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.19e-05	6.93e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.19e-05	6.93e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.16e-05	6.83e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL2—systemic lupus erythematosus	2.15e-05	6.78e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL2—systemic lupus erythematosus	2.15e-05	6.78e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL2—systemic lupus erythematosus	2.15e-05	6.78e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL2—systemic lupus erythematosus	2.12e-05	6.68e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MMP9—systemic lupus erythematosus	2.03e-05	6.42e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MMP9—systemic lupus erythematosus	2.03e-05	6.42e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MMP9—systemic lupus erythematosus	2.03e-05	6.42e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.02e-05	6.39e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.02e-05	6.39e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.02e-05	6.39e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MMP9—systemic lupus erythematosus	2e-05	6.33e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2e-05	6.3e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.99e-05	6.28e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL6—systemic lupus erythematosus	1.95e-05	6.16e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL6—systemic lupus erythematosus	1.95e-05	6.16e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL6—systemic lupus erythematosus	1.95e-05	6.16e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—EP300—systemic lupus erythematosus	1.93e-05	6.08e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—EP300—systemic lupus erythematosus	1.93e-05	6.08e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—EP300—systemic lupus erythematosus	1.93e-05	6.08e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL6—systemic lupus erythematosus	1.92e-05	6.08e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—EP300—systemic lupus erythematosus	1.9e-05	6e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.82e-05	5.76e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.82e-05	5.76e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.82e-05	5.76e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—IL6—systemic lupus erythematosus	1.8e-05	5.69e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—IL6—systemic lupus erythematosus	1.8e-05	5.69e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—IL6—systemic lupus erythematosus	1.8e-05	5.69e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.8e-05	5.68e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—IL6—systemic lupus erythematosus	1.78e-05	5.61e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.67e-05	5.29e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.67e-05	5.29e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.67e-05	5.29e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL6—systemic lupus erythematosus	1.66e-05	5.26e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL6—systemic lupus erythematosus	1.66e-05	5.23e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.65e-05	5.21e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	1.64e-05	5.18e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL6—systemic lupus erythematosus	1.26e-05	3.98e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL6—systemic lupus erythematosus	1.26e-05	3.98e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL6—systemic lupus erythematosus	1.26e-05	3.98e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL6—systemic lupus erythematosus	1.24e-05	3.93e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	1.04e-05	3.27e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALB—systemic lupus erythematosus	9.31e-06	2.94e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	8.91e-06	2.81e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	8.15e-06	2.57e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—EP300—systemic lupus erythematosus	6.78e-06	2.14e-05	CbGpPWpGaD
